See how pharma brands have used the Rare Medical Network to drive disease awareness, physician engagement, and clinical readiness.
A pharma manufacturer with a first-to-market targeted treatment for APDS, an ultra-rare primary immunodeficiency, needed to find HCPs who may have undiagnosed APDS patients in their care. Multiple content formats were deployed to generate awareness and educate key physician specialties.
A biopharma company developing treatment for rare seizure disorders like LGS and TSC sought to increase new adult diagnoses. The challenge: low HCP awareness and difficulty reaching “no-see” providers through conventional outreach. The initiative focused on educating HCPs about adult diagnosis recognition.
APDS is a rare primary immunodeficiency first identified in 2013, making it unfamiliar to most HCPs. Rare Medical Network and Equals 5 collaborated on an integrated content marketing approach to identify and educate healthcare providers — measuring knowledge and interest impact.
A small biopharma launched a therapy for WHIM syndrome, an ultra-rare primary immunodeficiency. Because symptoms present to both hematologists and immunologists, both specialties needed engagement. With limited budgets, the company required an efficient way to identify and engage high-value HCP leads.
An updated 2025 case study examining how targeted digital education across rare immunology specialties drove HCP awareness and lead generation for a WHIM syndrome therapy — with physician-level engagement data measured at every stage.
A medical affairs-focused case study on APDS, an ultra-rare primary immunodeficiency. Rare Medical Network deployed targeted content to educate key specialists, driving diagnosis rates and physician readiness in an underserved rare disease category.
A medical affairs case study for Lennox-Gastaut Syndrome, a rare and severe seizure disorder. The program focused on educating neurologists and pediatric specialists on diagnosis recognition and treatment pathways, with engagement tracked at the individual physician level.